CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
56.75
-0.08 (-0.15%)
Nov 21, 2024, 1:52 PM EST - Market open
CVS Health Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$73.00
Upside
+28.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $76 → $67 | Strong Buy | Reiterates | $76 → $67 | +18.07% | Nov 20, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $60 → $66 | Hold → Buy | Upgrades | $60 → $66 | +16.31% | Nov 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $68 → $58 | Buy | Maintains | $68 → $58 | +2.21% | Nov 15, 2024 |
| UBS | UBS | Hold Maintains $60 → $62 | Hold | Maintains | $60 → $62 | +9.26% | Nov 7, 2024 |
| Barclays | Barclays | Buy Maintains $75 → $71 | Buy | Maintains | $75 → $71 | +25.12% | Nov 7, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $61 → $60 | Hold | Maintains | $61 → $60 | +5.73% | Nov 4, 2024 |
| Mizuho | Mizuho | Buy Maintains $73 → $66 | Buy | Maintains | $73 → $66 | +16.31% | Oct 24, 2024 |
| Barclays | Barclays | Buy Maintains $82 → $75 | Buy | Maintains | $82 → $75 | +32.17% | Oct 23, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $66 → $76 | Strong Buy | Maintains | $66 → $76 | +33.93% | Oct 11, 2024 |
| Barclays | Barclays | Hold → Buy Upgrades $63 → $82 | Hold → Buy | Upgrades | $63 → $82 | +44.50% | Oct 10, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $62 → $75 | Buy | Maintains | $62 → $75 | +32.17% | Oct 8, 2024 |
| TD Cowen | TD Cowen | Hold → Strong Buy Upgrades $59 → $85 | Hold → Strong Buy | Upgrades | $59 → $85 | +49.79% | Oct 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $62 | Hold | Reiterates | $62 | +9.26% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $62 | Hold | Reiterates | $62 | +9.26% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $62 | Hold | Reiterates | $62 | +9.26% | Sep 10, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $68 | Buy | Reiterates | $68 | +19.83% | Sep 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.